Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

20 questions · 20 findings · 3 reviews · Urology

No studies found 3 · 15%GRADE not reported 0 · 0%Very low 4 · 20%Low 7 · 35%Moderate 6 · 30%High 0 · 0%

Laparaoscopic radical prostatectomy and robotic‐assisted laparoscopic radical prostatectomy vs open radical prostatectomy

Overall rate of surgical complications

Laparaoscopic radical prostatectomy and robotic‐assisted… showed no clear difference in overall surgical complications (short‐term) compared with open radical prostatectomy (low certainty).

1 finding from 1 review

Posterior reconstruction vs no posterior reconstruction

Urinary continence within 1 week after catheter removal MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

Posterior reconstruction showed no clear difference in urinary continence within 1 week after catheter removal MCID: 5%… compared with no posterior reconstruction (low certainty).

1 finding from 1 review

Posterior reconstruction vs no posterior reconstruction

Urinary continence 3 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

Posterior reconstruction showed no clear difference in urinary continence 3 months after surgery MCID: 5% absolute difference compared with no posterior reconstruction (low certainty).

1 finding from 1 review

Posterior reconstruction vs no posterior reconstruction

Serious adverse events · men (ages > 18 years) with clinically localized prostate cancer

Posterior reconstruction showed no clear difference in serious adverse events compared with no posterior reconstruction (moderate certainty).

1 finding from 1 review

Posterior reconstruction vs no posterior reconstruction

Urinary continence 6 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

Posterior reconstruction showed no clear difference in urinary continence 6 months after surgery MCID: 5% absolute difference compared with no posterior reconstruction (moderate certainty).

1 finding from 1 review

Posterior reconstruction vs no posterior reconstruction

Urinary continence 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

Posterior reconstruction showed no clear difference in urinary continence 12 months after surgery MCID: 5% absolute… compared with no posterior reconstruction (low certainty).

1 finding from 1 review

Posterior reconstruction vs no posterior reconstruction

Potency 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

It is very uncertain whether posterior reconstruction changes potency recovery 12 months after surgery MCID: 5% absolute difference compared with no posterior reconstruction (very low certainty).

1 finding from 1 review

Posterior reconstruction vs no posterior reconstruction

Positive surgical margins MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

Posterior reconstruction showed no clear difference in positive surgical margins MCID: 5% absolute difference compared with no posterior reconstruction (low certainty).

1 finding from 1 review

Retzius‐sparing RALP vs standard RALP

Urinary continence within 1 week after catheter removal MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

Retzius‐sparing RALP probably leads to higher urinary continence within 1 week after catheter removal MCID: 5%… compared with standard RALP (moderate certainty).

1 finding from 1 review

Retzius‐sparing RALP vs standard RALP

Urinary continence 3 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

Retzius‐sparing RALP may leads to higher urinary continence 3 months after surgery MCID: 5% absolute difference compared with standard RALP (low certainty).

1 finding from 1 review

Retzius‐sparing RALP vs standard RALP

Serious adverse events · men (ages > 18 years) with clinically localized prostate cancer

It is very uncertain whether retzius‐sparing RALP changes serious adverse events compared with standard RALP (very low certainty).

1 finding from 1 review

Retzius‐sparing RALP vs standard RALP

Urinary continence 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

Retzius‐sparing RALP showed no clear difference in urinary continence 12 months after surgery MCID: 5% absolute… compared with standard RALP (moderate certainty).

1 finding from 1 review

Retzius‐sparing RALP vs standard RALP

Potency 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

It is very uncertain whether retzius‐sparing RALP changes potency 12 months after surgery MCID: 5% absolute difference compared with standard RALP (very low certainty).

1 finding from 1 review

Retzius‐sparing RALP vs standard RALP

Positive surgical margins MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

Retzius‐sparing RALP may leads to higher positive surgical margins MCID: 5% absolute difference compared with standard RALP (low certainty).

1 finding from 1 review

Retzius‐sparing RALP vs standard RALP

Biochemical recurrence‐free survival · men (ages > 18 years) with clinically localized prostate cancer

It is very uncertain whether retzius‐sparing RALP changes biochemical recurrence‐free survival compared with standard RALP (very low certainty).

1 finding from 1 review